Mammotome Revolve
Payments companies reported to CMS as associated with Mammotome Revolve. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Mammotome Revolve, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Mammotome Revolve
These are the largest totals companies reported as associated with Mammotome Revolve. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Darius Gilvydis | Naperville, IL | Diagnostic Radiology | $8,360.00 |
| Robert Lenobel | Blue Ash, OH | Diagnostic Radiology | $1,078.05 |
| Sue Jane Grosso Rivas | Berkeley Heights, NJ | Diagnostic Radiology | $176.88 |
| Sean Enis | Englewood, NJ | General Practice | $140.82 |
| Mireille Aujero | Newark, DE | Diagnostic Radiology | $128.77 |
| Kevin Woisard | Portsmouth, VA | Diagnostic Radiology | $115.10 |
| Richard Ha | Seattle, WA | Diagnostic Radiology | $110.67 |
| Nathaniel Margolis | Middletown, NY | Diagnostic Radiology | $107.07 |
| Janette Gomez | Pittsburgh, PA | Surgery | $102.86 |
| Amish Patel | Morristown, NJ | Diagnostic Radiology | $96.28 |
Prescribed Mammotome Revolve?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.